|Day Low/High||360.01 / 377.80|
|52 Wk Low/High||196.78 / 380.76|
These two stocks have been consolidating and now appear ready to move in opposite directions.
We are shifting from a multi-position, swing-trading approach to a shorter-term approach.
Here is this week's roundup of the dumbest actions on Wall Street.
Morgan Stanley and Goldman Sachs get knocked just as their business shows signs of picking up.
Biotech is changing, so here's how to invest amid the industry's new gold rush.
Labs all over the world will be drooling over its new genetic-sequencing machine.
If you took some hard losses this year, here are some strategies for regaining ground.
The market is eagerly awaiting the September employment report, as a big divergence in either direction could affect stocks.
It will likely be difficult for Illumina to realize its revenue-growth plans -- and the uncertainties surrounding its business should keep a lid on the stock price.